175 related articles for article (PubMed ID: 22470116)
1. Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosa.
Ly NS; Yang J; Bulitta JB; Tsuji BT
Antimicrob Agents Chemother; 2012 Jun; 56(6):3453-6. PubMed ID: 22470116
[TBL] [Abstract][Full Text] [Related]
2. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates.
Lee JY; Ko KS
Diagn Microbiol Infect Dis; 2014 Mar; 78(3):271-6. PubMed ID: 24412662
[TBL] [Abstract][Full Text] [Related]
3. Development of colistin resistance in pmrA-, phoP-, parR- and cprR-inactivated mutants of Pseudomonas aeruginosa.
Lee JY; Chung ES; Na IY; Kim H; Shin D; Ko KS
J Antimicrob Chemother; 2014 Nov; 69(11):2966-71. PubMed ID: 24994873
[TBL] [Abstract][Full Text] [Related]
4. Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.
Lin J; Xu C; Fang R; Cao J; Zhang X; Zhao Y; Dong G; Sun Y; Zhou T
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383654
[TBL] [Abstract][Full Text] [Related]
5. The MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQ.
Chambers JR; Sauer K
J Bacteriol; 2013 Oct; 195(20):4678-88. PubMed ID: 23935054
[TBL] [Abstract][Full Text] [Related]
6. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa.
McPhee JB; Lewenza S; Hancock RE
Mol Microbiol; 2003 Oct; 50(1):205-17. PubMed ID: 14507375
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the PhoP-PhoQ and PmrA-PmrB two-component regulatory systems to Mg2+-induced gene regulation in Pseudomonas aeruginosa.
McPhee JB; Bains M; Winsor G; Lewenza S; Kwasnicka A; Brazas MD; Brinkman FS; Hancock RE
J Bacteriol; 2006 Jun; 188(11):3995-4006. PubMed ID: 16707691
[TBL] [Abstract][Full Text] [Related]
8. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS.
Fernández L; Gooderham WJ; Bains M; McPhee JB; Wiegand I; Hancock RE
Antimicrob Agents Chemother; 2010 Aug; 54(8):3372-82. PubMed ID: 20547815
[TBL] [Abstract][Full Text] [Related]
9. The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin.
Puja H; Bolard A; Noguès A; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964794
[TBL] [Abstract][Full Text] [Related]
10. Production of Norspermidine Contributes to Aminoglycoside Resistance in
Bolard A; Schniederjans M; Haüssler S; Triponney P; Valot B; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383668
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of PmrA and PmrB genes in colistin-resistant Pseudomonas aeruginosa strains via PCR method.
Heidari L; Sepahvand S; Darvishi M; Jafari R
Pak J Pharm Sci; 2019 May; 32(3 (Supplementary)):1175-1177. PubMed ID: 31303587
[TBL] [Abstract][Full Text] [Related]
12. Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides.
Macfarlane ELA; Kwasnicka A; Hancock REW
Microbiology (Reading); 2000 Oct; 146 ( Pt 10)():2543-2554. PubMed ID: 11021929
[TBL] [Abstract][Full Text] [Related]
13. Colistin resistance in Pseudomonas aeruginosa that is not linked to arnB.
Chung ES; Lee JY; Rhee JY; Ko KS
J Med Microbiol; 2017 Jun; 66(6):833-841. PubMed ID: 28621641
[TBL] [Abstract][Full Text] [Related]
14. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.
Moskowitz SM; Brannon MK; Dasgupta N; Pier M; Sgambati N; Miller AK; Selgrade SE; Miller SI; Denton M; Conway SP; Johansen HK; Høiby N
Antimicrob Agents Chemother; 2012 Feb; 56(2):1019-30. PubMed ID: 22106224
[TBL] [Abstract][Full Text] [Related]
15. Adaptive and Mutational Responses to Peptide Dendrimer Antimicrobials in Pseudomonas aeruginosa.
Ben Jeddou F; Falconnet L; Luscher A; Siriwardena T; Reymond JL; van Delden C; Köhler T
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015046
[TBL] [Abstract][Full Text] [Related]
16. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients.
Miller AK; Brannon MK; Stevens L; Johansen HK; Selgrade SE; Miller SI; Høiby N; Moskowitz SM
Antimicrob Agents Chemother; 2011 Dec; 55(12):5761-9. PubMed ID: 21968359
[TBL] [Abstract][Full Text] [Related]
17. Influence of PhoPQ and PmrAB two component system alternations on colistin resistance from non-mcr colistin resistant clinical E. Coli strains.
Wang CH; Siu LK; Chang FY; Tsai YK; Huang LY; Lin JC
BMC Microbiol; 2024 Apr; 24(1):109. PubMed ID: 38565985
[TBL] [Abstract][Full Text] [Related]
18. PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance.
Macfarlane EL; Kwasnicka A; Ochs MM; Hancock RE
Mol Microbiol; 1999 Oct; 34(2):305-16. PubMed ID: 10564474
[TBL] [Abstract][Full Text] [Related]
19. Mutations in
Romano KP; Warrier T; Poulsen BE; Nguyen PH; Loftis AR; Saebi A; Pentelute BL; Hung DT
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235628
[No Abstract] [Full Text] [Related]
20. Contribution of Novel Amino Acid Alterations in PmrA or PmrB to Colistin Resistance in
Sato T; Shiraishi T; Hiyama Y; Honda H; Shinagawa M; Usui M; Kuronuma K; Masumori N; Takahashi S; Tamura Y; Yokota SI
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
